Summary
Ismail Moghul is a co-founder and CTO with 12 years’ experience building regulated, cloud-native bioinformatics and clinical AI products that span genomics, ophthalmology imaging and clinical trials. Currently a PhD researcher at UCL Cancer Institute and Senior Bioinformatics Fellow at UCL Institute of Ophthalmology, he combines hands-on model development (OCT segmentation/classification, methylation analysis) with scalable pipelines — notably a cost-optimised AWS WGS pipeline that processes 30x data in under 45 minutes for <$1. He has founded and led multiple startups (Phenopolis/TrialSense, DocSnap, CANSoR, Eye2Gene), taking products from prototype to NHS/Pharma deployment and ISO-regulatory compliance. Comfortable both in the lab and the cloud, he routinely designs Nextflow/AWS Batch workflows and production inference with Lambda, and has delivered integrations onto medical devices. He mentors and teaches as a module lead and PhD committee member, and uniquely pairs deep research in cancer epigenomics with repeatable engineering that lowers per-sample costs at scale.
12 years of coding experience
10 years of employment as a software developer
Master's degree Bioinformatics, Master's degree Bioinformatics at Queen Mary University of London
University College London